olprinone has been researched along with Chronic Lung Injury in 1 studies
olprinone: RN refers to HCl; structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with olprinone reduced the numbers of polymorphonuclears in the BAL fluid, decreased the formation of most oxidation markers in the lungs, reduced lung edema and prevented a decrease in TAS in the lung homogenate compared to non-treated animals." | 1.38 | Selective phosphodiesterase 3 inhibitor olprinone attenuates meconium-induced oxidative lung injury. ( Calkovska, A; Drgova, A; Mokra, D; Pullmann, R, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mokra, D | 1 |
| Drgova, A | 1 |
| Pullmann, R | 1 |
| Calkovska, A | 1 |
1 other study available for olprinone and Chronic Lung Injury
| Article | Year |
|---|---|
Selective phosphodiesterase 3 inhibitor olprinone attenuates meconium-induced oxidative lung injury.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Bronchoalveolar Lavage Fluid; Disease Models, Anima | 2012 |